These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24504326)

  • 41. Identification of a novel GRIN2D variant in a neonate with intractable epileptic encephalopathy-a case report.
    Jiao J; Li L; Sun M; Fang J; Meng L; Zhang Y; Jia C; Ma L
    BMC Pediatr; 2021 Jan; 21(1):5. PubMed ID: 33397303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.
    Romaniello R; Zucca C; Tenderini E; Arrigoni F; Ragona F; Zorzi G; Bassi MT; Borgatti R
    J Child Neurol; 2014 Feb; 29(2):249-53. PubMed ID: 24170257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.
    Zhao Y; Zhang X; Bao X; Zhang Q; Zhang J; Cao G; Zhang J; Li J; Wei L; Pan H; Wu X
    BMC Med Genet; 2014 Feb; 15():24. PubMed ID: 24564546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compound heterozygous mutations in UBA5 causing early-onset epileptic encephalopathy in two sisters.
    Arnadottir GA; Jensson BO; Marelsson SE; Sulem G; Oddsson A; Kristjansson RP; Benonisdottir S; Gudjonsson SA; Masson G; Thorisson GA; Saemundsdottir J; Magnusson OT; Jonasdottir A; Jonasdottir A; Sigurdsson A; Gudbjartsson DF; Thorsteinsdottir U; Arngrimsson R; Sulem P; Stefansson K
    BMC Med Genet; 2017 Oct; 18(1):103. PubMed ID: 28965491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKIIα Phosphorylation of GluN2A and NMDA Receptor Trafficking.
    Mota Vieira M; Nguyen TA; Wu K; Badger JD; Collins BM; Anggono V; Lu W; Roche KW
    Cell Rep; 2020 Sep; 32(9):108104. PubMed ID: 32877683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two
    Kellner S; Abbasi A; Carmi I; Heinrich R; Garin-Shkolnik T; Hershkovitz T; Giladi M; Haitin Y; Johannesen KM; Steensbjerre Møller R; Berlin S
    Elife; 2021 Jul; 10():. PubMed ID: 34212862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy.
    Kodera H; Nakamura K; Osaka H; Maegaki Y; Haginoya K; Mizumoto S; Kato M; Okamoto N; Iai M; Kondo Y; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Hayasaka K; Sugahara K; Yuasa I; Wada Y; Matsumoto N; Saitsu H
    Hum Mutat; 2013 Dec; 34(12):1708-14. PubMed ID: 24115232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study.
    Kane LT; Costa BM
    J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
    Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
    Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and Functional Analysis of GRIN2A in Tumor Samples.
    Prickett TD; Gartner JJ; Samuels Y
    Methods Mol Biol; 2017; 1677():93-116. PubMed ID: 28986867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GRIN2A mutations in epilepsy-aphasia spectrum disorders.
    Yang X; Qian P; Xu X; Liu X; Wu X; Zhang Y; Yang Z
    Brain Dev; 2018 Mar; 40(3):205-210. PubMed ID: 29056244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
    Vyklicky V; Krausova B; Cerny J; Ladislav M; Smejkalova T; Kysilov B; Korinek M; Danacikova S; Horak M; Chodounska H; Kudova E; Vyklicky L
    Front Mol Neurosci; 2018; 11():110. PubMed ID: 29681796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features.
    Soldovieri MV; Ambrosino P; Mosca I; Miceli F; Franco C; Canzoniero LMT; Kline-Fath B; Cooper EC; Venkatesan C; Taglialatela M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results.
    Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V
    Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a GRIN2A de novo mutation associated with epilepsy and intellectual disability on NMDA receptor currents and Mg(2+) block in cultured primary cortical neurons.
    Marwick K; Skehel P; Hardingham G; Wyllie D
    Lancet; 2015 Feb; 385 Suppl 1():S65. PubMed ID: 26312887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating.
    Sobolevsky AI; Prodromou ML; Yelshansky MV; Wollmuth LP
    J Gen Physiol; 2007 Jun; 129(6):509-25. PubMed ID: 17504910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
    Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
    Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate.
    D'mello SA; Joseph WR; Green TN; Leung EY; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
    Cell Calcium; 2016 Dec; 60(6):384-395. PubMed ID: 27659111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.